 |
| Contact us |
|
| For media professionals: |
This contact information is for media professionals only. If you are not a member of the news media, please contact us via the phone number or email link at the bottom of the page.
|
|
| U.S. Communications: |
Lisa Buffington
(908) 981-6569
US.media-relations@sanofi-aventis.com
sanofi-aventis U.S.
55 Corporate Drive
Bridgewater, NJ 08807
Tel: 800-981-2491
|
| Via email |
|
|
|
|
 | 2007 Press Releases |
|
 | Press releases are intended for journalists, investors and shareholders. |
|
|
|
| December 10, 2007 |
| Study Shows that Low-Molecular Weight Heparin (LMWH) Was Associated With Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractioned Heparin (UFH) |
|
|
|
|
| November 19, 2007 |
| Powerful New Efficacy Data In Moderate And Severe Hypertensive Patients Supports FDA Approval Of Avalide® (Irbesartan-Hydrochlorothiazide) As The First Combination Therapy For Initial Use In Patients Likely To Need Multiple Drugs To Achieve Their Blood Pressure Goals |
|
|
|
|
| November 10, 2007 |
| New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis |
|
|
|
|
| November 07, 2007 |
| Retrospective Analysis Finds that Initiation of Insulin Glargine in Patients with Type 2 Diabetes was Associated with a Lower Incidence Rate of Myocardial Infarction as Compared with NPH Insulin |
|
|
|
|
| October 31, 2007 |
| Sanofi-aventis Announces Good Third Quarter Performance - Increase in 2007 full-year earnings growth guidance |
|
|
|
|
| October 24, 2007 |
| New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR® (zolpidem tartrate extended-release) tablets CIV |
|
|
|
|
| October 24, 2007 |
| Significant Survival Improvement with Taxotere®-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine |
|
|
|
|
| October 19, 2007 |
| Sixty Seconds That Can Change Your Life -- Simple test assesses osteoporosis risk and helps provide personal action plan for better bone health |
|
|
|
|
| October 02, 2007 |
| New Prescription Allergy Treatment Xyzal® (levocetirizine dihydrochloride) Now Available For Fall Allergy Season |
|
|
|
|
| October 01, 2007 |
| Taxotere® (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery |
|
|
|
|
| September 27, 2007 |
| FDA Approves New 300mg Loading Dose Tablet For Plavix® (Clopidogrel Bisulfate) |
|
|
|
|
| September 05, 2007 |
| The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients with Atrial Fibrillation or Flutter With No Observed Pro-Arrhythmia |
|
|
|
|
| August 27, 2007 |
| New 200 Mg Vial For Eloxatin® (Oxaliplatin Injection) Offers Greater Convenience And Efficiency Of Preparation |
|
|
|
|
| August 01, 2007 |
| First half: solid results in a difficult context. Plavix® recovers its position in the US, full impact expected in H2 |
|
|
|
|
| July 30, 2007 |
| SoloSTAR®, the First Prefilled Disposable Insulin Pen for Lantus®, is Now Available in the United States |
|
|
|
|
| June 29, 2007 |
| Rimonabant Regulatory Update in the United States |
|
|
|
|
| June 27, 2007 |
| Taxotere® (docetaxel) Granted FDA Priority Review for Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck Prior to Chemoradiotherapy and Surgery |
|
|
|
|
| June 24, 2007 |
| Apidra® Improved A1C In People With Type 2 Diabetes When Added to Basal Insulin And Oral Antidiabetic Treatments (BOT) |
|
|
|
|
| June 23, 2007 |
| Results of Two Head-to-Head Studies Demonstrated Long-Acting Insulin Lantus® Lowered Free Fatty Acid Levels Equal to or Better |
|
|
|
|
| June 21, 2007 |
| Basketball Hall of Fame Coach Chuck Daly Creates Game Plan to Manage the Symptoms of Benign Prostatic Hyperplasia (BPH) |
|
|
|
|
| June 19, 2007 |
| Sanofi-aventis and Bristol-Myers Squibb Prevail in U.S. Plavix® Patent Litigation |
|
|
|
|
| June 15, 2007 |
| FDA approves new route of administration for rapid-acting Apidra® providing an additional treatment option for hospitalized diabetes patients with high blood sugar levels |
|
|
|
|
| June 13, 2007 |
| FDA Advisory Committee did not recommend approval of rimonabant (Zimulti®) for use in obese and overweight patients with associated risks factors |
|
|
|
|
| June 04, 2007 |
| UPDATED STUDY RESULTS REINFORCE SURVIVAL BENEFIT OF TAXOTERE® (DOCETAXEL) FOR MEN WITH ADVANCED, HORMONE-RESISTANT PROSTATE CANCER |
|
|
|
|
| June 04, 2007 |
| ELOXATIN® (oxaliplatin injection)-BASED CHEMOTHERAPY SETS NEW TREATMENT BENCHMARK IN PATIENTS WITH METASTATIC COLORECTAL CANCER |
|
|
|
|
| June 04, 2007 |
| THE ELOXATIN®-BASED REGIMEN (FOLFOX4) SIGNIFICANTLY IMPROVED PROGRESSION FREE SURVIVAL WHEN GIVEN BEFORE AND AFTER SURGERY IN PATIENTS WITH RESECTABLE LIVER METASTASES FROM COLORECTAL CANCER |
|
|
|
|
| June 03, 2007 |
| OXFORD BIOMEDICA AND SANOFI-AVENTIS REPORT NEW TROVAX® PHASE II TRIAL RESULTS IN RENAL CANCER |
|
|
|
|
| June 03, 2007 |
| S-1, A NOVEL ORAL FLUOROPYRIMIDINE, WHEN COMBINED WITH CISPLATIN, DEMONSTRATES SIGNIFICANT IMPROVEMENT IN OVERALL SURVIVAL OF ADVANCED GASTRIC CANCER PATIENTS OVER S-1 ALONE |
|
|
|
|
| June 03, 2007 |
| FOLFOX4 (ELOXATIN®-based chemotherapy) AFTER SURGERY IMPROVES OVERALL SURVIVAL IN PATIENTS WITH EARLY (STAGE III) COLON CANCER |
|
|
|
|
| June 03, 2007 |
| “My child matters” program one-year report shows measurable improvement in cancer care for children in developing and newly industrialized countries |
|
|
|
|
| June 02, 2007 |
| RESULTS OF VEGF TRAP (AFLIBERCEPT) HIGHLIGHTED AT ASCO 2007 ANNUAL MEETING |
|
|
|
|
| May 29, 2007 |
| Data to be presented at ASCO 2007 highlights sanofi-aventis commitment to cancer care and research |
|
|
|
|
| May 29, 2007 |
| FDA approves XYZAL® (levocetirizine dihydrochloride) tablets for the relief of seasonal and year round allergies, and chronic hives |
|
|
|
|
| May 18, 2007 |
| FDA Approves LOVENOX® (enoxaparin sodium injection) for the most severe type of heart attack |
|
|
|
|
| May 15, 2007 |
| Sanofi-aventis calls for an effective policy against drug counterfeiting |
|
|
|
|
| May 08, 2007 |
| Sopranos Star Aida Turturro speaks out to encourage fellow diabetes patients to take control |
|
|
|
|
| May 03, 2007 |
| Full-year guidance raised on good 2007 first-quarter results |
|
|
|
|
| April 30, 2007 |
| FDA Approves Lantus SoloStar® - A new prefilled disposable insulin pen for use with LANTUS® in people with Type 1 and Type 2 diabetes |
|
|
|
|
| April 20, 2007 |
| The Lancet publishes PREVAIL study results showing LOVENOX® superiority over unfractionated heparin for reducing the risk of venous thromboembolism in patients with acute ischemic stroke |
|
|
|
|
| April 17, 2007 |
| The U.S. Food and Drug Administration Approves New ACTONEL Dose to Treat and Prevent Postmenopausal Osteoporosis |
|
|
|
|
| March 26, 2007 |
| Rimonabant USA: Update |
|
|
|
|
| March 25, 2007 |
| Data Shows That Omission of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Medical Patients Is Frequent and Leads to Higher Risk of Deep-Vein Thrombosis (DVT) |
|
|
|
|
| March 16, 2007 |
| Award-winning actress and singer Lainie Kazan travels across the country urging Americans to understand the signs, symptoms and risk factors for Deep-Vein Thrombosis (DVT) |
|
|
|
|
| March 13, 2007 |
| ALLEGRA® (fexofenadine hydrochloride) Oral Supsension now available to help manage seasonal allergy symptoms in children |
|
|
|
|
| March 12, 2007 |
| Sanofi-aventis Debuts AgingWithBeauty.com |
|
|
|
|
| March 06, 2007 |
| Actor Cheryl Hines is tired of counting sheep to sleep…and is painting them instead |
|
|
|
|
| March 01, 2007 |
| New, Once-a-Day Fixed-Dose Combination Against Malaria Now Available |
|
|
|
|
| February 12, 2007 |
| Sanofi-aventis announces update to US Prescribing Information for KETEK® (telithromycin) |
|
|
|
|
| February 12, 2007 |
| Rimonabant USA: Update |
|
|
|
|
| February 07, 2007 |
| FDA grants priority review to LOVENOX® (enoxaparin sodium injection) supplemental new drug application (sNDA) for acute heart attack |
|
|
|
|
| February 06, 2007 |
| Tim Rothwell appointed Chairman of Sanofi-aventis Group U.S. pharmaceutical activities; Greg Irace named President and CEO of U.S. pharmaceutical operations |
|
|
|
|
| February 01, 2007 |
| Sanofi-aventis applauds new national standards for prophylaxis of venous thromboembolism in surgical patients |
|
|
|
|
| January 19, 2007 |
| S-1 oral anticancer agent improves patients’ survival in adjuvant gastric cancer trial versus surgery alone |
|
|
|
|
|
|
